Share on StockTwits

CytRx (NASDAQ:CYTR) posted its quarterly earnings results on Wednesday. The company reported ($0.28) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.20) by $0.08, American Banking & Market News reports.

Shares of CytRx (NASDAQ:CYTR) opened at 3.32 on Wednesday. CytRx has a one year low of $2.00 and a one year high of $8.35. The stock has a 50-day moving average of $3.85 and a 200-day moving average of $4.41. The company’s market cap is $185.2 million.

On a related note, analysts at Aegis reiterated a “buy” rating on shares of CytRx in a research note on Monday, June 2nd.

CytRx Corporation as (NASDAQ:CYTR) is a biopharmaceutical research and development company engaged in the development of high-value human therapeutics, specializing in oncology.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.